Companies / NovoCure Ltd

NovoCure Ltd

Nasdaq: NVCRCIK 1645113ST. HELIER

Financials · FY2025

Revenue$655.35M
Net income$-136.23M
Total debt$195.05M
Cash$93.70M
Diluted EPS$-1.22
Shares outstanding116.4M

Ownership

116.4M shares outstanding · as of Jul 17, 2026
81.5%Institutions
Ownership
Institutions81.48%94,875,298
Public float18.52%21,570,542

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 14

View all →
Insider% of sharesShares
Ben Arye BarakFormerGeneral Counsel
Brackmann ChristophChief Financial Officer
Cordova AshleyCEOFormer Chief Executive Officer
Doyle William FExecutive Chairman · Director
Hung DavidDirector
Leonard Frank XCEOFormerChief Executive Officer
Leupin NicolasFormerFormer Chief Medical Officer

Institutional holders 247

View all →
HolderValue% of shares
Fmr LLC$217.18M14.42%
BlackRock, Inc.$203.22M11.52%
Vanguard Group Inc$141.69M9.41%
Soleus Capital Management, L.P.$110.30M7.33%
Morgan Stanley$65.55M4.35%
State Street Corporation$43.43M2.46%
Geode Capital Management, LLC$27.38M2.16%
Quantinno Capital Management LP$25.99M1.73%
Renaissance Technologies LLC$16.91M1.33%
Nuveen, LLC$16.46M1.09%

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 3, 2026Doyle William F
Executive
SellOrdinary Shares$646.4K-51K
-12.63%
349,727
0.30% of shares
medium
Mar 5, 2026Paravasthu Mukund
Executive
SellOrdinary Shares$595.7K-43K
-37.26%
72,832
0.06% of shares
medium
Mar 3, 2026Doyle William F
Executive
SellOrdinary Shares$286.4K-21K
-6.10%
328,397
0.28% of shares
medium
Apr 28, 2026Vernon W Anthony
Director
ExerciseOrdinary Shares$244.9K+22K
+12.00%
200,602
0.17% of shares
low
Mar 4, 2026Cordova Ashley
CEO
OtherOrdinary Shares$234.6K-18K
-4.01%
422,570
0.36% of shares
low
Feb 27, 2026Cordova Ashley
CEO
OtherOrdinary Shares$158.7K-12K
-2.64%
426,028
0.37% of shares
low
Feb 27, 2026Leonard Frank X
CEO
SellOrdinary Shares$133.0K-10K
-2.80%
338,011
0.29% of shares
medium
Feb 27, 2026Weinberg Uri
Executive
SellOrdinary Shares$103.3K-7K
-3.37%
213,757
0.18% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A0
Soleus Capital Master Fund, L.P.Passive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
NVCRG6674U108